Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 35% ± 21% | |
lung | 8 studies | 22% ± 3% | |
eye | 6 studies | 25% ± 5% | |
peripheral blood | 5 studies | 19% ± 4% | |
heart | 4 studies | 24% ± 3% | |
intestine | 4 studies | 19% ± 3% | |
adipose | 4 studies | 25% ± 7% | |
uterus | 3 studies | 27% ± 8% | |
kidney | 3 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 5980.36 | 578 / 578 | 100% | 24.70 | 1152 / 1155 |
intestine | 100% | 6562.40 | 966 / 966 | 100% | 24.75 | 525 / 527 |
ovary | 100% | 4062.19 | 180 / 180 | 98% | 14.15 | 422 / 430 |
breast | 100% | 4917.59 | 459 / 459 | 98% | 21.08 | 1094 / 1118 |
stomach | 99% | 3652.00 | 355 / 359 | 99% | 26.37 | 282 / 286 |
kidney | 100% | 3520.94 | 89 / 89 | 97% | 26.47 | 877 / 901 |
brain | 98% | 3445.59 | 2578 / 2642 | 99% | 16.75 | 700 / 705 |
esophagus | 97% | 4746.15 | 1398 / 1445 | 100% | 26.78 | 183 / 183 |
prostate | 100% | 4392.87 | 244 / 245 | 96% | 16.92 | 482 / 502 |
pancreas | 96% | 2254.56 | 316 / 328 | 98% | 18.39 | 175 / 178 |
adrenal gland | 100% | 7362.22 | 258 / 258 | 94% | 14.81 | 216 / 230 |
bladder | 100% | 6224.43 | 21 / 21 | 94% | 17.02 | 472 / 504 |
thymus | 100% | 4514.92 | 652 / 653 | 93% | 19.80 | 564 / 605 |
skin | 99% | 7147.30 | 1790 / 1809 | 92% | 22.48 | 436 / 472 |
uterus | 100% | 7824.13 | 170 / 170 | 88% | 14.90 | 404 / 459 |
liver | 90% | 1938.01 | 204 / 226 | 77% | 10.02 | 314 / 406 |
adipose | 100% | 4987.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8727.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 9836.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3145.20 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 3943.30 | 822 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 17.47 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 84% | 13.75 | 38 / 45 |
eye | 0% | 0 | 0 / 0 | 54% | 5.19 | 43 / 80 |
peripheral blood | 26% | 2693.76 | 238 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006974 | Biological process | DNA damage response |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0072562 | Cellular component | blood microparticle |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZBTB38 |
Protein name | Zinc finger and BTB domain-containing protein 38 ZBTB38 protein Zinc finger and BTB domain containing 38 |
Synonyms | |
Description | FUNCTION: Transcriptional regulator with bimodal DNA-binding specificity. Binds with a higher affinity to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' but can also bind to E-box elements (5'-CACGTG-3'). Can also bind specifically to a single methyl-CpG pair. Represses transcription in a methyl-CpG-dependent manner . Plays an important role in regulating DNA replication and common fragile sites (CFS) stability in a RBBP6- and MCM10-dependent manner; represses expression of MCM10 which plays an important role in DNA-replication . Acts as a transcriptional activator. May be involved in the differentiation and/or survival of late postmitotic neurons (By similarity). . |
Accessions | Q32Q70 D6RAC4 ENST00000321464.7 Q8NAP3 D6RE69 D6RHD1 ENST00000509813.1 ENST00000509842.5 D6R9U6 ENST00000510726.1 ENST00000513258.5 ENST00000509883.5 D6RBC4 ENST00000503809.5 ENST00000510338.5 D6RJE1 D6R9J6 D6RGK1 ENST00000514251.5 ENST00000507722.5 ENST00000513570.1 A0A1B0GV48 ENST00000441582.2 ENST00000636289.1 D6R9I1 ENST00000637056.1 ENST00000504673.5 D6RC86 |